Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors	Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, head and neck squamous cell carcinoma, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, skin disorder, squamous cell carcinoma, stomach disorder	Recruiting	Phase 1	2026-09-29		NCT07360314

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
EMD Serono Research & Development Institute, Inc.	18
Merck KGaA, Darmstadt, Germany	31

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BC Cancer - Vancouver - BC Cancer Agency	Vancouver	Canada	1
Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center	Huntersville	United States	1
Hospital Universitari Vall d'Hebron - VHIO - Oncology - Phase I Unit	Barcelona	Spain	1
National Cancer Center Hospital	Tokyo	Japan	20
NEXT Houston	Galveston	United States	1
NEXT Madrid - Hospital Universitario Quironsalud Madrid	Madrid	Spain	1
NEXT Oncology - PARENT	San Antonio	United States	1
Princess Margaret Cancer Centre	Toronto	Canada	12
Yale University - Yale University School of Medicine	New Haven	United States	1